Post hoc analysis of a phase 3 ixekizumab vs placebo trial in nonradiographic axial spondyloarthritis: patients meeting established or proposed MRI sacroiliac joint definitions had similar baseline features and week-16 outcomes; proposed did not outperform established.
Secondary analysis
Baraliakos et al. Comparison of the established ASAS definition and preliminary proposed data-driven cut-offs for inflammatory and structural MRI lesions in the sacroiliac joints for eligibility of patients with nonradiographic axial spondyloarthritis in clinical trials